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Abstract
Expression quantitative trait locus (eQTL) analyses identify genetic mark-
ers associated with the expression of a gene. Most up-to-date eQTL studies
consider the connection between genetic variation and expression in a single
tissue. Multi-tissue analyses have the potential to improve findings in a single
tissue, and elucidate the genotypic basis of differences between tissues. In this
paper we develop a hierarchical Bayesian model (MT-eQTL) for multi-tissue
eQTL analysis. MT-eQTL explicitly captures patterns of variation in the pres-
ence or absence of eQTL, as well as the heterogeneity of effect sizes across
tissues. We devise an efficient Expectation-Maximization (EM) algorithm for
model fitting. Inferences concerning eQTL detection and the configuration of
eQTL across tissues are derived from the adaptive thresholding of local false
discovery rates, and maximum a-posteriori estimation, respectively. We also
provide theoretical justification of the adaptive procedure. We investigate the
MT-eQTL model through an extensive analysis of a 9-tissue data set from the
GTEx initiative.
Keywords: GTEx; Hierarchical Bayesian model; Local false discovery rate;
MT-eQTL; Tissue specificity.
2
1 Introduction
Genetic variation in a population is commonly studied through the analysis of single
nucleotide polymorphisms (SNPs), which are genetic variants occurring at specific
sites in the genome. Expression quantitative trait locus (eQTL) analysis seeks to
identify genetic variants affecting the expression of one or more genes: a gene-SNP
pair for which the expression of the gene is associated with the value of the SNP is
referred to as an eQTL. Identification of eQTL has proven to be a useful tool in the
study of pathways and networks that underlie disease in human and other populations
(cf. Kendziorski and Wang, 2006; Wright and others , 2012).
To date, most eQTL studies have considered the effects of genetic variation on
expression within a single tissue. A natural next step in understanding the genomic
variation of expression is the simultaneous analysis of eQTL in multiple tissues. Multi-
tissue eQTL analysis has the potential to improve the findings of single tissue analyses
by borrowing strength across tissues, and to address fundamental biological questions
about the nature and source of variation between tissues. An important feature of
multiple tissue studies is that a SNP may be associated with the expression of a gene
in some tissues, but not in others. Thus a full multi-tissue analysis must identify
complex patterns of association across multiple tissues.
Until recently, understanding of multi-tissue eQTL relationships was limited by a
shortage of true multi-tissue data sets, requiring the assimilation of data or results
from different studies involving distinct populations, measurement platforms, and
analysis protocols. By contrast, the GTEx initiative (The GTEx Consortium, 2015)
and related projects are currently generating genetic data from dozens of tissues in
several hundred individuals, greatly expanding our potential understanding of eQTLs
across multiple tissues. The size and complexity of these emerging multi-tissue data
sets have created the need to expand existing statistical tools for eQTL analysis.
In this paper we introduce and study a hierarchical Bayesian model for the si-
multaneous analysis of eQTL in multiple tissues. We particularly focus on cis-eQTL,
where a SNP is located near the transcription start site of a gene. We call the method
MT-eQTL (MT stands for multi-tissue). The dimension of the MT-eQTL model is
equal to the number of tissues. In this paper, we primarily consider a moderate di-
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mension, typically between 1 and 10. Importantly, we do not seek to model the full
expression and genotype data, but focus instead on the vector z of Fisher transformed
correlations between expression and genotype across tissues. Figure 1b (upper panel)
shows a density scatter plot of the z-statistics for the lung and thyroid data from
GTEx pilot data freeze as reported by The GTEx Consortium (2015). The lower
panel illustrates the results of the MT-eQTL model: z pairs close to the origin for
which no eQTL are detected have been removed, resulting in the central white re-
gion; detected eQTL are colored according to whether an eQTL is detected in both
tissues (light gray points) or a single tissue (dark gray and black points). Our model
explicitly captures patterns of variation in the presence or absence of eQTL, as well
as the heterogeneity of effect sizes across tissues.
The contribution of the paper is five-fold: 1) introduction of a novel hierarchical
Bayesian model for multi-tissue eQTL analysis; 2) development of an efficient EM
algorithm for estimating the parameters of the model; 3) analysis of the properties
of the model; 4) rigorous theoretical arguments showing that model-based testing
procedures control FDR under realistic assumptions; 5) applications to the GTEx
data.
1.1 Related work
Most existing multi-tissue analyses extract eQTL individually from each tissue and
then apply post-hoc procedures to assess commonality and specificity (Brown and
others , 2013; Dimas and others , 2009; Fu and others , 2012; Nica and others , 2011).
Recently, several joint analysis approaches were proposed. Gerrits and others (2009)
used an ANOVA model to study the genotype effect on a transcript across several
cell types. Petretto and others (2010) used a sparse Bayesian multivariate regression
model to identify eQTL at multiple loci for same transcripts in many tissues. More
recently, Flutre and others (2013) developed a Bayesian model and a permutation-
based approach to identify eQTL in multiple tissues. The computation is prohibitive
for a moderate number of tissues and a large number of gene-SNP pairs. Sul and
others (2013) proposed a “Meta-Tissue” method that combines linear mixed models
with meta-analysis. It focuses on one gene-SNP pair at a time. However, the method
cannot borrow strength across gene-SNP pairs for eQTL detection, or provide global
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(a) Raw data format
(b) MT-eQTL input and output
Figure 1: (a) Illustration of the typical data format with two tissues. Genotype
data G is available for m SNPs and each of n samples. Expression measurements
are available for p genes; sample sets for different tissues may not be the same. (b)
z-statistics for lung and thyroid: density plot for all local gene-SNP pairs (top), and
scatter plot for significant local gene-SNP pairs with tissue specificity by gray scale
(bottom). The gene-SNP pairs deemed insignificant are omitted, leading to the white
space at the center of the plot. The remaining points are colored according to their
assessed tissue specificity: dark gray points correspond to the Lung-specific eQTL;
black points correspond to the Thyroid-specific eQTL; light gray points correspond
to the cross-tissue eQTL.
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parameter estimates to characterize eQTL patterns.
In the literature, eQTL analyses are generally divided into two categories: gene-
level analysis and SNP-level analysis. The former focuses on the identification of
eQTL genes, typically by averaging evidence over all candidate SNPs. The latter
treats all gene-SNP pairs equally and aims at identifying significantly associated pairs.
Both Gerrits and others (2009) and Sul and others (2013) studied eQTL at the SNP
level while Petretto and others (2010) and Flutre and others (2013) are gene-level
studies. Gene-level analysis tries to address linkage disequilibrium by assuming there
is at most one causal SNP for each gene. However, it cannot provide a list of candidate
SNP loci which are potential eQTL for a gene. In this paper, we shall focus on the SNP
level study, providing a complementary view of the problem. We will also address the
computational issue and the lack-of-power concern by exploiting an empirical Bayes
approach.
2 The MT-eQTL Model
2.1 Format of Multi-Tissue eQTL Data
The general data format for the multi-tissue eQTL problem is as follows. For each
of n donors we have full genotype information, and measurements of gene expression
in at least one of K tissues. Let G be an m × n matrix containing the measured
genotype of each donor in the study at m SNPs. The entries take values 0, 1, and 2,
typically coded as the number of minor allele variants. Each column of G corresponds
to a donor, and each row corresponds to a SNP. The measured transcript levels for
tissue k are contained in a p × nk matrix Xk, where p is the number of genes, and
nk ≤ n is the number of donors for tissue k. The number of donors nk can vary
widely among tissues, and even if two tissues have similar numbers of samples, they
may have few common donors. The data available for the purposes of multi-tissue
eQTL analysis has the form (G,X1, . . . ,XK). Figure 1a gives an illustration of the
typical data format with two tissues.
In most cases eQTL analysis is preceded by several preprocessing steps and covari-
ate adjustment. Covariate adjustment is necessary because genotype and expression
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data usually contain confounding factors. Some confounders, such as gender, are
observed, while others are of unknown technical or biological origin. To identify
the unknown confounding factors, most studies use principal components, surrogate
variables (Leek and Storey, 2007), or PEER factors (Stegle and others , 2012) as co-
variates. In Section 4.1, we shall discuss the preprocessing procedure of the GTEx
data. For now, we just assume that the expression data and genotype data have been
appropriately residualized for confounders, so the comparison of these residualized
quantities are partial correlations adjusted for covariates.
2.2 Multivariate z-Statistic from Single Tissue Correlations
Denote a gene by i ∈ {1, . . . , p} and a SNP by j ∈ {1, . . . ,m}. We focus on a subset
Λ of the full index set {1, . . . , p} × {1, . . . ,m} that consists of pairs (i, j) such that
SNP j is located within a fixed distance (usually 100 Kilobases or 1 Megabase) of the
transcription start site of gene i.
Let λ = (i, j) be a gene-SNP pair of interest. Let rλk and ρλk denote, respec-
tively, the sample and population correlation of transcript i and SNP j in tissue
k. We use the Pearson product-moment correlation for several reasons: 1) with
proper transformation of transcript data, the sample correlation has a known, normal
distribution (Winterbottom, 1979), which is the basis of the proposed multi-tissue
model; 2) the Pearson correlation has close connection with the regression coefficient
in a simple linear model relating transcript abundance and genotype (the foundation
of most single-tissue eQTL studies). Note that the sample correlation rλk depends
only on the nk measurements from donors of tissue k. The vector of correlations
rλ = (rλ1, . . . , rλK) captures the association between the expression of transcript i
and the value of genotype j in K tissues. Relationships between different tissues
will be reflected in correlations between the entries of rλ. These features make rλ a
natural starting point for a multi-tissue eQTL model.
We build a multivariate model for the correlation vector rλ. Let h(rλ) =(
h(rλ1), . . . , h(rλK)
)
be the vector obtained by applying the Fisher transformation
h(r) = 1
2
log
(
1+r
1−r
)
to each component of rλ. Let d
1/2 := (
√
d1 − 3, . . . ,
√
dK − 3) be
a scaling vector, where dk is the degrees of freedom for Xk and G, equal to nk minus
the number of covariates used to correct genotype and expression for samples in tissue
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k. Finally, define the vector zλ = d
1/2 · h(rλ) where u · v denotes the Hadamard
(entry-wise) product of vectors u and v. Let Zλ denote the random vector for zλ. If
we assume that the expression measurements Xk are approximately normal, standard
arguments for the Fisher transformation (Winterbottom, 1979) imply that h(rλk) is
approximately normal with mean h(ρλk) and variance (dk − 3)−1. By a routine mul-
tivariate extension of this fact, Zλ is approximately normally distributed with mean
µλ = d
−1/2 · h(ρλ). The variance stabilizing property of the Fisher transformation
and our choice of scaling ensures that the variance of each entry Zλk of Zλ is close to
one, regardless of ρλ. In particular, if the true correlation ρλk between transcript i
and SNP j for tissue k is zero, then Zλk is approximately standard normal. Thus the
k-th entry of the observed vector zλ is a z-statistic for testing ρλk = 0 vs. ρλk 6= 0.
The use of z-statistics greatly reduces the data complexity and magnitude, without
losing much information regarding gene-SNP associations. It facilitates statistical
modeling and computation. Importantly, the components of Zλ are not independent
due to the correlation of effect sizes and sample overlaps in different tissues. Capturing
this dependence is one of the key features of the MT-eQTL model, which is described
in detail below.
2.3 Hierarchical Model
Let λ = (i, j) be a gene-SNP pair in Λ. MT-eQTL is a multivariate, hierarchical
Bayesian model for the random vector Zλ. In detail, we assume that
Zλ |µλ ∼ NK (µλ,∆) , (1)
µλ = Γλ ·αλ, (2)
Γλ ∼ p on {0, 1}K , (3)
αλ ∼ NK(µ0,Σ), independent of Γλ. (4)
We briefly explain the rationale behind the model setup. The first relation is a
consequence of the Fisher transformation, where µλ denotes the true effect sizes of
the gene-SNP pair λ across the K tissues. The K × K covariance matrix ∆ has
diagonal values 1; its off-diagonal values capture the correlations between any two
tissues arising from the underlying sampling process. In practice, the off-diagonal
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values are typically weakly positive due to overlapping donors for different tissues.
Since the true effect sizes are unknown in practice, in (2), we build a hierarchical
Bayesian model for µλ based on two assumptions: when the SNP has no effect on
the gene in a tissue, the true effect size is 0; when the SNP regulates the gene in a
tissue, the true effect size follows a random distribution. Thus µλ is represented as a
Hadamard product of two random vectors, Γλ and αλ.
The random vector Γλ is a configuration vector for the gene-SNP pair λ, indicating
whether there is an eQTL in each of the K tissues. As in (3), the prior distribution
of Γλ is a multinomial distribution with p being the probability mass function. The
multinomial distribution has 2K components, each being a length-K vector of 0′s and
1′s. In particular, Γλ = 0 indicates there is no eQTL in any tissue for the gene-SNP
pair λ, and Γλ = 1 indicates there are eQTL in all tissues for this particular gene-
SNP pair. The random vector αλ is an eQTL effect size vector for the gene-SNP
pair λ, capturing the true effect size in each tissue if there is an eQTL. In (4), we
give αλ a Gaussian prior, with mean µ0 and covariance Σ. The mean parameter
µ0 is a length-K vector capturing the average eQTL effect sizes in all tissues, and
the K ×K matrix Σ represents the covariance structure of eQTL effect sizes across
multiple tissues. The diagonal values indicate the variation of effect sizes in different
tissues; and the off-diagonal values, typically strongly positive, reflect the relations of
effect sizes between tissues.
In the model, there are four major parameters, ∆, p, µ0 and Σ. The parameters
characterize multi-tissue effect sizes for all gene-SNP pairs, and carry important bi-
ological interpretations. We will exploit an empirical Bayes approach to estimate all
parameters from data.
2.4 Mixture Model and Estimation
The hierarchical model (1)-(4) describing the distribution of Zλ is fully specified
by θ = (µ0,∆,Σ,p), which consists of 2
K + K2 + K − 1 real-valued parameters.
Estimation of, and inference from, the hierarchical model is based on an equivalent
mixture representation.
If U is distributed as NK(µ,Σ) and γ is a fixed vector in {0, 1}K , then one may
readily verify that the entrywise product U ·γ is distributed as NK
(
µ ·γ,Σ ·γγT ). A
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straightforward argument then shows that the hierarchical model (1)-(4) is equivalent
to a mixture model
Zλ ∼
∑
γ∈{0,1}K
pγ NK
(
µ0 · γ, ∆ + Σ · γγT
)
. (5)
The mixture model is readily interpretable. Each component of the model corresponds
to a unique configuration γ, or equivalently, a unique pattern of tissue specificity. The
model component corresponding to γ = 0 represents the case in which there are no
eQTL in any tissue, and has associated (null) distribution NK(0,∆). The model
component corresponding to γ = 1 represents the case in which there are eQTL
in every tissue, and has associated distribution NK(µ0,∆ + Σ). Other values of γ
represent intermediate cases in which there are eQTL in some tissues (those with
γk = 1) and not in others (those with γk = 0).
We adopt an empirical Bayes approach, estimating the model parameters θ =
(µ0,∆,Σ,p) from the observed z-statistics {zλ : λ ∈ Λ} by maximizing the likelihood
derived from (5). Beginning with the work of Newton and others (2001) and Efron and
others (2001), empirical Bayes approaches have been applied to hierarchical models
in a number of genetic applications, most notably the study of differential expression
and co-expression in gene expression microarrays (Dawson and Kendziorski, 2012;
Efron, 2008; Newton and others , 2004; Smyth and others , 2004).
Directly maximizing the joint log likelihood of the model (5) across gene-SNP pairs
is computationally intractable. On the one hand, observations for different gene-SNP
pairs may be correlated, as each gene may contain multiple SNPs and neighboring
SNPs may have relatively strong linkage disequilibrium. On the other hand, the like-
lihood function for each gene-SNP pair has 2K components, each corresponding to a
weighted multivariate Gaussian likelihood function with overlapping model parame-
ters. Note that the parameters in the model (5) determine, and are determined by,
the marginal distribution of the vectors Zλ, and do not depend on their joint distri-
bution. We address the issue of correlated observations by maximizing a marginal
composite likelihood, which is defined as the product of the marginal likelihoods of
all considered gene-SNP pairs. As such, it does not attempt to capture correlation
between different gene-SNP pairs. For typical eQTL analyses, in which the number of
gene-SNP pairs is large and average pairwise correlations are low, we expect the use
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of marginal composite likelihood estimation has little effect on statistical efficiency.
To address the difficulty of parameter estimation, we exploit an EM algorithm
by treating the underlying configuration vector for each gene-SNP pair as a latent
variable. As a result, the estimation of the probability mass function p can be sepa-
rated from the estimation of µ0, ∆ and Σ. The optimization with respect to p has
a closed-form solution in each iteration. Furthermore, in cis-eQTL analysis, the null
configuration γ = 0 and the full alternative configuration γ = 1 together usually
account for the majority of the prior weight. When estimating µ0, ∆ and Σ, if we
only focus on the log likelihood terms corresponding to these two configurations, each
parameter has an explicit estimate. As such, we use a modified EM algorithm with
the two-term approximation, which greatly reduces the computational cost. Simu-
lation studies show that such approximation has little affect on the accuracy of the
estimation. More details of the model fitting algorithm can be found in Section 1 of
the online supplementary material.
2.5 Marginal Compatibility
In eQTL studies with multiple tissues, it is desirable if the model for a subset of tissues
is compatible with the model for a superset of tissues in the sense that the former can
be obtained from the latter via marginalization. We refer to this property as marginal
compatibility. From the model interpretation point of view, the property guarantees
that parameters (e.g., prior probabilities of different eQTL configurations, covariance
of effect sizes in different tissues) corresponding to a set of tissues do not depend on
whether we observe just those tissues or a superset of the tissues. It is crucial in
multi-tissue eQTL studies as we essentially always analyze a set of some hypothetical
superset of tissues that we do not observe. From the model fitting point of view,
with the property, we only need to fit the full model with all available tissues once.
The model for any subset of tissues can be obtained directly through marginalization
without refitting.
To elaborate, let S ⊆ {1, . . . , K} be a subset of r tissues, with 1 ≤ r ≤ K. The
mixture model (5) has two important compatibility properties: (i) the marginaliza-
tion of the full model to S has the same general form as the model derived from S
alone; and (ii) the parameters of the marginal model are obtained by restricting the
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parameters of the full model to S. The following definition and lemma makes these
statements precise. See Section 2 in the online supplementary material for a proof of
the lemma.
Definition: Let S ⊆ {1, . . . , K} with cardinality |S| = r. For each vector u ∈ RK
let uS = (uk : k ∈ S) ∈ Rr be the vector obtained by restricting u to the entries in
S. Similarly, for each matrix A ∈ RK×K let AS = {akl : k, l ∈ S} be the r× r matrix
obtained by retaining only the rows and columns with indices in S. Note that if A is
non-negative (positive) definite, then AS is non-negative (positive) definite as well.
Lemma 2.1. If Z ∈ RK be a random vector having the mixture distribution (5), then
ZS ∼
∑
ζ∈{0,1}r
pS,ζNr
(
µ0S · ζ, ∆S + ΣS · ζζT
)
where (pS,0, · · · , pS,1) is the probability mass function on {0, 1}r obtained by marginal-
izing p to S, i.e., pS,ζ =
∑
γ:γS=ζ
pγ.
3 Multi-Tissue eQTL Inference
Once fit, the mixture model (5) provides the basis for inference about eQTL across
tissues. When the number of gene-SNP pairs is large, as in the GTEx example in
Section 4, θ can be accurately estimated from data. At the level of posterior inference
for gene-SNP pairs, we therefore regard θ as fixed and known. For data sets with small
sample sizes, approximate standard errors for the components of θ can be obtained
from the likelihood via the observed information matrix.
Denote the density of the distribution NK
(
µ0 · γ, ∆ + Σ · γγT
)
associated with
the configuration γ ∈ {0, 1}K by fγ . Thus under the mixture model (5) the random
vector Zλ has density f(z) =
∑
γ pγ fγ(z), z ∈ RK . In view of this expression
and the hierarchical model (1)-(4), one may regard Zλ as one element of a jointly
distributed pair (Γλ,Zλ), where
Γλ ∼ p and Zλ |Γλ ∼ fγ . (6)
We carry out multi-tissue eQTL analysis based on the posterior distribution of the
configuration Γλ given the observed vector of z-statistics zλ. Two inference problems
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are of central interest: one is eQTL detection, in all tissues and in a subset of tissues;
the other is the assessment of eQTL tissue specificity given eQTL is present in at
least one tissue.
3.1 Detection of eQTL Using the Local False Discovery Rate
A primary goal of multi-tissue analysis is testing each transcript-SNP pair for the
presence of an eQTL in at least one tissue. This can be formulated as a multiple
testing problem:
H0,λ : Γλ = 0 versus H1,λ : Γλ 6= 0 for λ ∈ Λ. (7)
For λ = (i, j) ∈ Λ the null hypothesis H0,λ asserts that SNP j is not an eQTL for
transcript i in any tissue, while the alternative H1,λ asserts that there is an eQTL
between i and j in at least one tissue.
The null hypotheses can also be expressed in the form H0,λ : Zλ ∼ NK
(
0, ∆
)
. One
may derive a p-value for each λ directly from the null distribution, and convert it to
control the overall false discovery rate (FDR) (cf. Benjamini and Hochberg, 1995;
Storey and Tibshirani, 2003). However, this procedure ignores relevant information
about the distribution of Zλ under the alternative that is contained in the mixture
model.
We address the multiple testing problem (7) using the local false discovery rate
introduced by Efron and others (2001) in the context of an empirical Bayes analysis of
differential expression in microarrays. Other applications of the local false discovery
rate to genomic problems can be found in Newton and others (2004), Efron (2007),
and Efron (2008). To simplify notation, let (Γ,Z) denote a generic pair distributed
as (Γλ,Zλ).
Definition: The local false discovery rate of an observed z-statistic vector z under
the model (5) is defined by
η(z) := P(Γ = 0 |Z = z) = p0f0(z)
f(z)
. (8)
Let α ∈ (0, 1) be a target false discovery rate (FDR) for the multiple testing
problem (7). Vectors z for which the local false discovery rate η(z) is small provide
evidence for the alternative Γ 6= 0. We carry out testing of gene-SNP pairs using a
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step-up procedure applied to the running average of the ordered local false discover
rates (Cai and Sun, 2009; Newton and others , 2004).
Local FDR Step-Up Procedure: Target FDR = α
1. Given: Observed z-statistic vectors {zλ : λ ∈ Λ}.
2. Enumerate the elements of Λ as λ1, . . . , λN so that η(zλ1) ≤ · · · ≤ η(zλN ).
3. Reject hypotheses H0,λ1 , . . . ,H0,λL , where L is the largest integer such that
L−1
∑L
l=1 η(zλl) ≤ α.
3.2 Theoretical Justification of the Local FDR Approach
In order to better understand the local FDR step-up procedure, and to assess its
performance, it is useful to express the procedure in an equivalent form. As noted by
Efron and others (2001), the false discovery rate associated with a rejection region
R ⊆ Rk for the multiple testing problem (7) is given by P(Γ = 0 |Z ∈ R). They
establish the following elementary fact, which exhibits a connection between FDR
and local FDR.
Proposition 3.1. If R ⊆ Rk is such that P(Z ∈ R) > 0, then P(Γ = 0 |Z ∈ R) =
E(η(Z) |Z ∈ R).
As noted above, vectors z for which η(z) is small provide evidence against Γ = 0,
so it is natural to reject H0,λ when η(zλ) falls below an appropriate threshold. Consider
rejection regions of the form R(t) = {z : η(z) ≤ t} for t ∈ (0, 1). Given a target false
discovery rate α, we wish to find t such that α = P(Γ = 0 |Z ∈ R(t)). By Proposition
3.1 this is equivalent to finding t ∈ (0, 1) such that F (t) = α, where
F (t) := E(η(Z) | η(Z) ≤ t) = E[η(Z) I(η(Z) ≤ t)]
P(η(Z) ≤ t) .
The empirical analog of F (t) is the ratio
Fˆ (t) =
∑
λ∈Λ η(zλ) I(η(zλ) ≤ t)∑
λ∈Λ I(η(zλ) ≤ t)
,
which depends only on η(·) and the observed vectors {zλ}. The function F (t) is
strictly increasing and continuous (see Section 3.1 in the online supplementary mate-
rial for proof). Thus if F (t) and Fˆ (t) were equal, the local FDR step-up procedure
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and the idealized threshold procedure would coincide. In general, F (t) and Fˆ (t) will
be different, but multiplying the numerator and denominator of Fˆ (t) by |Λ|−1 it is
evident that the two functions will be close if |Λ| is large and the dependence among
the observed z-vectors is not extreme. Asymptotic control of the FDR by the step-up
procedure is established in Theorem 3.2 below. The proof can be found in Section 3
of the online supplementary material.
Let Λ∗ ⊆ N×N be an infinite index set, and let Λ1,Λ2, . . . ⊆ Λ∗ be a sequence of
finite subsets of Λ∗. Let α ∈ (0, 1) be a target FDR that is less than the maximum
value of η(z). For each n ≥ 1 let {(Γλ,Zλ) : λ ∈ Λn} be jointly distributed pairs
having the same distribution as (Γ,Z). We wish to assess the performance of the local
FDR step-up procedure, which rejects H0,λ when η(Zλ) ≤ θˆn = sup{t : Fˆn(t) ≤ α}
where
Fˆn(t) =
∑
λ∈Λn η(Zλ) I(η(Zλ) ≤ t)∑
λ∈Λn I(η(Zλ) ≤ t)
0 < t < 1.
The number of false discoveries and total discoveries for the procedure are equal to
Mn =
∑
λ∈Λn I(Γλ = 0) I(η(Zλ) ≤ θˆn) and Nn =
∑
λ∈Λn I(η(Zλ) ≤ θˆn).
Theorem 3.2. Let (Γ,Z) have joint distribution given by Model (6) with parameters
(µ0,∆,Σ,p). Assume that ∆ is positive definite and that the diagonal entries of Σ
are positive. If Fˆn(t) → F (t) in probability for each t ∈ (0, 1) then EMn/ENn → α
as n→∞.
The ratio of expectations EMn/ENn is sometimes referred to as the marginal false
discovery rate (m-FDR). Cai and Sun (2009) established optimality properties and
m-FDR control of several local FDR based testing procedures, including the step-up
procedure used here, under independence and monotonicity assumptions. However,
these assumptions are typically violated in the setting of interest to us here. The
monotonicity assumption, which in the present case involves the relationship between
the distributions of the local FDR η(Zλ) under H0,λ and H1,λ, does not appear to hold.
Moreover, in eQTL data there are typically significant correlations between nearby
SNPs (linkage disequilibrium), leading to to complex, non-stationary correlations
between the gene-SNP based vectors Zλ.
Theorem 3.2 makes no explicit assumptions on the joint distribution of the vectors
Zλ; instead it relies on the relatively weak condition that Fˆn(t)→ F (t) in probability.
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This condition holds, for example, under the (very mild) assumption that the variance
of the numerator and the denominator of Fˆn(t) are of order o(|Λn|2). The variance
decay assumption concerns the family of all gene-SNP pairs, across all measured genes
instead of a single gene. Although the SNPs co-located with a particular gene may be
highly correlated, correlations are generally weak, or zero, across distant genes. These
distal pairs dominate the index set Λn, and so the variance decay assumption should
be satisfied in any cis eQTL analysis involving a large number of genes. When the
assumption holds, the conclusion of the theorem may be strengthened to Mn/Nn =
α + oP (1).
3.3 Analysis for Subsets of Tissues
In some problems, a subset S ⊆ {1, . . . , K} of the available tissues may be of primary
interest. The multiple testing framework described above can be adapted to the
tissues in S in two primary ways. The first is to construct a model based only
on the tissues in S and use the resulting local FDR to identify multi-tissue eQTL.
However, this approach does not make use of the available data from tissues outside
S and as such it does not borrow strength from commonalities among tissues. As an
alternative, one may use the marginal local FDR for S, defined by
ηS(z) := P(ΓS = 0 |Z = z) =
∑
γ:γS=0
pγfγ(z)
f(z)
. (9)
Here ΓS and γS denote, respectively, the restriction of the vectors Γ and γ to the
tissues in S, while pγ , fγ and f correspond to the full model (5). We emphasize that
the marginal local FDR ηS(z) is a function of the complete vector of z-statistics, and
therefore depends on the fitted model for the full set of tissues. In Section 4.3, we
have shown that the marginal local FDR derived from the full data set is uniformly
more powerful than the local FDR derived from a subset of the data in detecting
eQTLs in a subset of tissues. More numerical results can be found in Section 4.3 of
the supplementary material.
3.4 Assessments of Tissue Specificity
Testing gene-SNP pairs is typically the first step in multi-tissue eQTL analysis. Re-
jection of H0,λ is based on evidence that λ is an eQTL in at least one of the available
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tissues. More detailed statements about the pattern of eQTL across tissues can be
made using information about the full configuration vector Γλ. If the hypothesis H0,λ
is rejected, a natural estimate of Γλ is the maximum a-posteriori (MAP) configuration
defined by
γ̂λ = arg max
γ∈{0,1}K\0
p(γ | zλ) = arg max
γ∈{0,1}K\0
pγ fγ(zλ).
As an alternative, one may compute the marginal posterior probability of an eQTL
in each tissue k, namely p(Γλ,k = 1|zλ) =
∑
γ:γk=1
p(γ|zλ) =
∑
γ:γk=1
pγ fγ(zλ)/f(zλ),
and declare an eQTL in tissue k if this marginal probability exceeds a predefined
threshold. Both MAP and thresholding of the marginal posterior extend to subsets
of tissues.
3.5 Testing a Family of Configurations
The goal of the multiple testing problem (7) is to determine whether the configuration
Γλ of a gene-SNP pair is equal to 0 or belongs to the complementary set {0, 1}K \{0}.
More generally, one may test membership of Γλ in any fixed subset T ⊆ {0, 1}K of
configurations. The associated testing problem can be written as
HT0,λ : Γλ ∈ T c versus HT1,λ : Γλ ∈ T, λ ∈ Λ. (10)
A test statistic for (10) can be obtained by marginalizing the full local FDR (8) as
ηT (z) := P(Γ ∈ T c |Z = z) =
∑
γ:γ∈T c pγfγ(z)
f(z)
.
The local FDR step-up procedure can then be applied to the values {ηT (zλ)} in order
to control the overall FDR in (10).
4 GTEx Data Analysis
In this section, we apply the MT-eQTL model and inference procedures to the GTEx
pilot data freeze (The GTEx Consortium, 2015). A pointer to the publicly available
data is at http://www.broadinstitute.org/gtex/.
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4.1 Data Preprocessing
We focus on nine primary tissues having between 80 and 160 samples: adipose, artery,
blood, heart, lung, muscle, nerve, skin, and thyroid. In what follows, tissues will be
ordered alphabetically. In total, there are 175 genotyped individuals with expression
data in at least one of these tissues (the sample information can be found in Figure
S1 of the supplementary material).
Each entry of the genotype data matrix G records the number of minor allele
variants of one donor at one SNP locus. Any missing value at a locus was imputed
by the corresponding row average. Loci with minor allele frequency less than 5%
in all genotyped individuals were discarded, resulting in slightly less than 7 million
SNPs. The expression level for each gene in each tissue and sample is measured by the
number of mapped reads per kilobase per million reads (RPKM). Genes having fewer
than 10 samples with RPKM greater than 0.1 in some tissue were discarded, leaving
slightly more than 20 thousand genes. To improve robustness, the gene expression
values across samples in a tissue were inverse quantile normalized.
Fifteen PEER factors were identified from the expression data from each tissue,
and three principal components were identified from the genotype data. With an
additional covariate for gender, we obtained nineteen covariates in total. For each
tissue, the confounding effects were adjusted by residualizing the expression data and
the corresponding genotype data on nineteen covariates respectively. Consequently,
the degree of freedom for each tissue is equal to the sample size in that tissue minus
19.
4.2 Model Fit
We focus on testing of cis-eQTL, restricting our attention to SNPs that lie within
100 kilobases of the transcription start site of a gene, yielding roughly 10 million
gene-SNP pairs of interest. Subsequently, the full 9-dimensional MT-eQTL model
was fit using the modified EM algorithm described in Section 2.4 with the parameter
µ0 set to zero. Fitting the full model took less than 24 hours, and required less
than 8 gigabytes of RAM, on a desktop computer with 2.93GHz Intel Xeon CPU. A
comparison of timing results for fitting sub-models of different dimensions between
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our method and the Meta-Tissue method (Sul and others , 2013) can be found in
Section 5 of the supplementary material.
In what follows we denote the estimated model parameters by θ = (∆,Σ,p). Val-
ues of the estimated parameters can be found in Section 5 of the online supplementary
material. The off-diagonal values of ∆ are all positive but small in scale (between
0.07 and 0.2), suggesting that donor overlap among tissues and other features of the
experimental design have a weak but positive effect on the correlations of effect sizes
across tissues. The diagonal values of Σ indicate modest heterogeneity of effect size
variation across tissues. The off-diagonal values of Σ reflect positive, often large,
correlation of effect sizes arising from commonalities among tissues.
The fitted probability mass function p assigns probabilities to each of the 29
possible eQTL configurations. The most likely configuration is 0 with p0 = 0.6808,
indicating that about 68% of the gene-SNP pairs do not have an eQTL in any tissue.
This is consistent with previous studies (Wright and others , 2014). To summarize p,
we sum up the prior probabilities of configurations with the same Hamming weight
(defined as the number of 1s in a length-9 binary configuration sequence). This
provides an overview of the overall probability of seeing an cis-eQTL in k tissues,
where k ranges from 0 to 9. We note, however, that the probabilities for configurations
with the same Hamming weight may be quite different. The total prior probabilities
are shown in Figure 2 in the log scale. The U-shape curve indicates that for cis-eQTL
analysis, the most likely configurations are eQTL in no tissue, in a single tissue, or
in all tissues, and the least likely configurations are those with eQTL in roughly half
the tissues. We remark that the pattern may only apply to cis-eQTL but not to
trans-eQTL.
4.3 Results
Applied to the full 9-dimensional model with FDR threshold α = .05, the local FDR
step-up procedure identified roughly 1.28 million gene-SNP pairs (roughly 12% of the
total) with an eQTL in at least one tissue. We subsequently applied the MAP rule
to each significant discovery in order to assess tissue specificity. To validate the dis-
coveries, we also applied the Meta-Tissue method to the same data set. Meta-Tissue
produces a p value for each gene-SNP pair for testing the existence of eQTL in any
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Figure 2: Summary of the estimated eQTL probabilities from the cis-eQTL analysis
of the GTEx data. Each circle represents the log (base 10) of the probability of a
gene-SNP pair having eQTL in k out of 9 tissues, where k ranges from 0 to 9.
tissue. We further adjusted the p values (Benjamini and Yekutieli, 2001) to control
the FDR. About 80% of the MT-eQTL discoveries (i.e., 1.03 million) are replicated
in Meta-Tissue, providing a highly concordant result. We further investigated the
unique discoveries of each method (about 250 thousand from MT-eQTL, and 177
thousand from Meta-Tissue). The left panel of Figure 3 shows the Meta-Tissue p
values of the unique discoveries from MT-eQTL. Small p values are enriched, indicat-
ing the unique MT-eQTL discoveries are well supported by Meta-Tissue. The right
panel of Figure 3 presents the MT-eQTL local FDRs of the unique discoveries from
Meta-Tissue. The unique Meta-Tissue discoveries are only moderately supported by
MT-eQTL. The MT-eQTL provides a systematic way to leverage information across
gene-SNP pairs, and offers explicit estimates of model parameters with critical bio-
logical interpretation.
A unique advantage of MT-eQTL over Meta-Tissue is the ease of eQTL tissue
specificity assessment. To facilitate the visualization of eQTL discoveries, let us focus
on a two-tissue MT-eQTL model. As an example, Figure 1b shows scatter plots of
z-statistics for lung and thyroid. The upper panel shows the density plot of the raw
z-statistics (MT-eQTL input); the lower panel only shows the discoveries with eQTL
in at least one of the tissues (MT-eQTL output). The z-statistic vectors deemed
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Figure 3: The left panel is the histogram of the Meta-Tissue p values for the 250
thousand unique discoveries from MT-eQTL, from the GTEx analysis of eQTL in at
least one tissue; The right panel is the histogram of the MT-eQTL local FDRs for
the 177 thousand unique discoveries in Meta-Tissue.
insignificant are omitted, leading to the white space at the center of the plot. The
remaining points are colored according to their assessed tissue specificity based on
the MAP approach: dark gray represents the configuration (1, 0) in which there is
an eQTL in tissue 1 but not tissue 2; black represents the configuration (0, 1) in
which there is an eQTL in tissue 2 but not tissue 1; and light gray represents the
configuration (1, 1) in which there is an eQTL in both tissues. The overall shape of
each plot is a tilted ellipse, with extreme values along the main diagonal and, to a
lesser extent, along the coordinate axes. As expected, significant points close to one
of the coordinate axes show evidence for an eQTL in a single tissue (tissue specific
eQTL), while those along the positive diagonal show evidence for eQTL in both tissues
(common eQTL). We remark that this analysis easily extends to an arbitrary number
of tissues.
MT-eQTL also effectively leverages information in multiple tissues to improve
eQTL detection in a single or a subset of tissues. To investigate how the use of
auxiliary tissues increases statistical power, we studied a sequence of nested MT-
eQTL models and focused on eQTL discoveries in a single tissue. For each of the
nine tissues, we first fitted the 1-dimensional model with just the primary tissue and
then added other tissues one by one alphabetically to get a sequence of super-models.
For each considered model, we applied the adaptive thresholding procedure to the
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marginal local FDR for the primary tissue, and recorded the number of significant
discoveries in that tissue. Figure 4 shows the number of significant discoveries versus
the dimension of a model. Each curve corresponds to a case where one of the nine
tissues is set to be the primary tissue. The number of eQTL discoveries in each
primary tissue increases with the dimension of a model.
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Figure 4: The number of significant discoveries in a primary tissue versus the dimen-
sion of a MT-eQTL model. Each curve corresponds to a case where one of the nine
tissues is set to be the primary tissue. The FDR threshold is fixed to be 0.05.
5 Conclusion
In this paper, we proposed a hierarchical Bayesian model, MT-eQTL, for multi-tissue
eQTL analysis. We adopted an empirical Bayes approach to estimate the model and to
perform inferences. We also proved a substantial theoretical property to support the
method in a realistic setting. The proposed methodology greatly enhances classical
single-tissue eQTL analysis methods by accounting for the information shared among
tissues.
There are a number of interesting directions for future research. Perhaps the most
important is to extend the proposed framework to a large number (e.g., K ≥ 10) of
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tissues. The large tissue setting poses real challenges as the total number of configura-
tions grows exponentially in the number of tissues, making the current implementation
excessively slow and computationally costly. Another direction is to relax the assump-
tion that the covariance matrix ∆ in Model (5) is constant across gene-SNP pairs.
Different genes may have distinct correlation patterns between tissues, which might
warrant the use of gene-specific covariance matrices in setting where the number of
samples is large. Lastly, it is of interest to extend the method to the identification of
trans-eQTLs, which exhibit higher levels of tissue-specificity than cis-eQTLs (Jo and
others , 2016).
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Supplementary Materials
A Model Fitting and Parameter Estimation
A.1 Matrix eQTL
The set of correlations rλk for all transcript-SNP pairs λ and tissues k = 1, . . . , K
can be conveniently calculated using the R package Matrix eQTL by Shabalin (2012).
The package is designed for fast eQTL analysis in individual tissues. Matrix eQTL
accounts for covariates and can filter transcript-SNP pairs by the distance between
their genomic locations. Once Matrix eQTL is applied separately for each tissue, the
t-statistics it reports can be transformed into correlations using the simple transfor-
mation
rλk =
tλk√
dk + t2λk
where dk is the number of degrees of freedom in the tests for tissue k and is also
reported by Matrix eQTL. The set of correlations can then be combined in a single
matrix with rows rλ.
A.2 Modified EM Algorithm
We wish to estimate the parameter θ = (µ0,∆,Σ,p) from the observed z-statistics
{zλ : λ ∈ Λ}, which are computed directly from the sample correlations rλk obtained
from Matrix eQTL. In order to make the estimation of θ tractable, we assume that
the random vectors Zλ are independent. The likelihood of the model then has a
simple product form, depending only on the unknown parameter θ, and the observed
z-statistics {zλ}:
L({zλ}|θ) =
∏
λ∈Λ
∑
γ∈{0,1}K
pγ fγ(zλ | θ), (11)
where fγ(· | θ) is the probability density function of the NK
(
µ0 · γ,∆ + Σ · γγT
)
distribution.
Remark: It is important to note that the parameter θ concerns only the (common)
marginal distribution of the random vectors Zλ, and is unaffected by their dependence.
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The assumption that the random vectors Zλ are independent facilitates estimation of
θ, but does not impose any constraints on the marginal dependence structure of Zλ.
We estimate the parameter θ by seeking to maximize the logarithm of the like-
lihood (11). The log-likelihood is not concave, and there appears to be no closed
form solution to the maximization problem. Thus one must to rely on iterative algo-
rithms that produce a sequence of parameters θ(t) converging to a (local) maximum
of the likelihood. A direct approach employing a generic software routine for nu-
merical maximization of the likelihood function would be computationally intensive,
as each iteration would require multiple (at least 2K) calculations of the likelihood
function around the estimate obtained at the previous iteration. A much faster con-
vergence can be achieved by applying a modification of Expectation Maximization
(EM) algorithm. Details are given below.
We treat the unobserved tissue-specificity information vector Γλ ∈ {0, 1}K as a
latent variable. The joint likelihood of both observed and latent variables is:
L(z,γ | θ) = pγ fγ(z | θ).
The EM algorithm operates in an iterative fashion. Let θ(t) = (µ
(t)
0 ,∆
(t),Σ(t),p(t)) be
the estimate of the model parameters after t iterations. The estimate θ(t+1) is defined
by
θ(t+1) = arg max
θ
Q(θ : θ(t)),
where
Q(θ : θ(t)) =
∑
λ
EΓλ|zλ,θ(t)
[
logL(zλ,Γλ|θ)
]
.
The expectation of the log-likelihood is calculated with respect to the conditional dis-
tribution of Γλ given the observed vector of correlations zλ and the model parameters
θ(t).
Consider the conditional expectation appearing in Q(θ : θ(t)). Let p(γ | θ) denote
the probability of the configuration γ under the probability mass function p associated
with the parameter θ, and define
p(γ | z, θ) = P(Γλ = γ | z, θ) = p(γ | θ)fγ(z | θ)∑
γ′ p(γ
′ | θ)fγ′(z | θ)
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The objective function Q(θ : θ(t)) then has the form
Q(θ : θ(t)) =
∑
λ
∑
γ
p(γ | zλ, θ(t))
[
log p(γ | θ) + log fγ(zλ | θ)
]
Maximization of Q with respect to θ leads to the explicit formula
p(γ | θ(t+1)) =
∑
λ
p(γ | zλ, θ(t))
/
|Λ|
where |Λ| is the number of gene-SNP pairs under consideration. There appears to be
no closed form solution for the iterates of µ
(t)
0 , Σ
(t) and ∆(t). However, in practice,
most of the probability mass of p is concentrated at the two extreme cases γ = 0
and γ = 1, reflecting the fact that most transcript-SNP pairs are associated in no
tissues or all tissues. Approximating Q(·) by restricting the second sum to γ = 0, 1
leads to explicit (approximate) estimates of µ0, Σ and ∆ via the following first order
conditions:
∆(t+1) =
∑
λ
p(0 | zλ, θ(t))zλzTλ
/∑
λ
p(0 | zλ, θ(t))
µ
(t+1)
0 =
∑
λ
p(1 | zλ, θ(t))zλ
/∑
λ
p(1 | zλ, θ(t))
Σ(t+1) + ∆(t+1) =
∑
λ
p(1 | zλ, θ(t))(zλ − µ(t+1)0 )(zλ − µ(t+1)0 )T
/∑
λ
p(1 | zλ, θ(t))
At some iterations the estimates Σ(t+1) may fail to be non-negative definite. In such
cases we force Σ(t+1) to be non-negative definite by calculating its singular value
decomposition and dropping terms with negative coefficients (negative eigenvalues).
Starting with an initial parameter value θ(0), we perform sequential updates in
the manner described above until the change in the likelihood falls below a pre-
set threshold. To assess the reliability of the estimate one may run the algorithm
multiple times using distinct starting points. In our experiments the algorithm tends
to converge to the same estimate regardless of the starting point.
B Proof of Lemma 2.1
Proof. Let S be a subset of {1, . . . , K} with cardinality |S| = r. It follows from the
defining properties of the multivariate normal distribution that if U ∼ NK(µ, A) then
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US ∼ Nr(µS, AS). Therefore we have that
ZS ∼
∑
γ∈{0,1}K
pγ Nr
(
(µ0 · γ)S, (∆ + Σ · γγT )S
)
(12)
Here and in the remainder of the proof we follow the convention that γ ranges over
{0, 1}K , and ζ ranges over {0, 1}r. Elementary arguments show that
(µ0 · γ)S = µ0,S · γS and (∆ + Σ · γγT )S = ∆S + ΣS · γSγTS
It then follows from (12) that
ZS ∼
∑
γ∈{0,1}K
pγ Nr
(
µ0,S · γS, ∆S + ΣS · γSγTS
)
=
∑
ζ∈{0,1}r
∑
γ:γS=ζ
pγ Nr
(
µ0,S · γS, ∆S + ΣS · γSγTS
)
=
∑
ζ∈{0,1}r
Nr
(
µ0,S · ζ, ∆S + ΣS · ζζT
) ∑
γ:γS=ζ
pγ
=
∑
ζ∈{0,1}r
pζ,SNr
(
µ0,S · ζ, ∆S + ΣS · ζζT
)
,
which is the desired expression for distribution of ZS.
C Proof of Theorem 3.2
C.1 Continuity and Monotonicity of F (t)
Lemma C.1. Let U be a bounded, non-negative random variable. For t ≥ 0 define
G(t) = E[U |U≤ t ] = E[U I(U≤ t) ]
P(U≤ t) . (13)
Then the following hold:
1. G is non-decreasing and right continuous;
2. If P(U = t) = 0 then G is continuous at t;
3. If P(a < U < b) > 0 for each 0 < a < b < L then G is strictly increasing on
(0, L).
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Proof. To show that G is non-decreasing it suffices to show that G(t+ δ)−G(t) ≥ 0
for each fixed t ≥ 0 and δ > 0. If G(t) = 0 then the result is immediate as the
function G is non-negative. If G(t) is positive, then
G(t+ δ)−G(t) = E[U I(U≤ t+ δ) ]
P(U≤ t+ δ) −
E[U I(U≤ t) ]
P(U≤ t)
=
E[U I(U≤ t+ δ) ]P(U≤ t) − E[U I(U≤ t) ]P(U≤ t+ δ)
P(U≤ t+ δ)P(U≤ t) .
By elementary arguments the numerator of the last fraction can be expressed as
E[U I(t < U≤ t+ δ) ]P(U≤ t) − E[U I(U≤ t) ]P(t < U≤ t+ δ)
≥ tP(t < U≤ t+ δ)P(U≤ t) − tP(U≤ t)P(t < U≤ t+ δ) (14)
= 0.
Thus G is non-decreasing. Right continuity of G follows by applying the monotone
convergence theorem to the numerator and denominator in (13). If P(U = t) = 0
then continuity of G at t follows from the dominated convergence theorem in a similar
fashion. Finally, if P(t < U < t+ δ) > 0 then the inequality in (14) is strict, and the
final claim follows by considering t ∈ [0, L) and δ > 0 such that t+ δ < L.
Lemma C.2. For i = 0, . . . ,m let fi be the density of the d-variate normal distribu-
tion Nd(µi,Σi) and let c1, . . . , cm be positive constants. If at least one of f1, . . . , fm is
not equal to f0, then
md
({
x : f0(x) =
∑m
j=1 cj fj(x)
})
= 0
where md(·) denotes Lebesgue measure on Rd.
Proof. Define h(x) = f0(x) −
∑m
j=1 cj fj(x) and let A = {x : h(x) = 0}. As h is
continuous, A is a closed subset of Rd. We establish the result by way of contradiction.
Consider first the case in which d = 1 and h(x) = 0 for each x ∈ R. By an easy
argument, we can assume that the densities fi, i = 0, 1, . . . ,m are distinct and that
m ≥ 1. Let µi and σi be, respectively, the mean and variance of the distribution
specified by the density fi. Let (σj, µj) be the largest element, under the usual
28
lexicographic order, of the set {(σi, µi) : 0 ≤ i ≤ m}. Considering the limit of
h(x)/fj(x) as x tends to infinity, we conclude that cj = 0 if j 6= 0 or 1 = 0 if j = 0. In
either case we obtain a contradiction, and therefore h(x) cannot be identically equal
to zero.
The remainder of the proof proceeds by induction on d. Consider first the case
d = 1. Note that h(x) is an analytic function of the real variable x. If m1(A) > 0
then there exists M < ∞ such that m1(A ∩ [−M,M ]) > 0. In particular, there
are infinitely many points of A in the compact set [−M,M ]. Thus A has a limit
point x0, and h(x0) = 0 as A is closed. As the zeros of a non-zero analytic function
are necessarily isolated, it follows that h(x) is identically zero. This contradicts the
argument given above, and we conclude that m1(A) = 0.
Assume now that the lemma holds for dimensions 1, . . . , d − 1, and consider the
general case of dimension d. Suppose that md(A) > 0. By Fubini’s theorem, there
exist a Borel measurable set B ⊂ R such that (i) m1(B) > 0 and (ii) for every xd ∈ B
the section
A(xd) = {xd−11 : (xd−11 , xd) ∈ A} ⊆ Rd−1
has (d− 1)-dimensional Lebesgue measure greater than zero. (Here xd−11 denotes the
ordered sequence x1, . . . , xd−1.) Note that h(x) = 0 can be written in the equivalent
form
0 = f0(x
d−1
1 |xd) f0(xd) −
m∑
j=1
cj fj(x
d−1
1 |xd) fj(xd) x ∈ A (15)
where fj(x
d−1
1 |xd) denotes the conditional density of xd−11 given xd under fj, and
fj(xd) denotes the marginal density of xd under fj. If for each xd ∈ B the conditional
densities fj(x
d−1
1 |xd) are equal on A(xd) then (15) becomes
0 = f0(xd) −
m∑
j=1
cj fj(xd) xd ∈ B,
which contradicts the induction hypothesis. Suppose then that for some xd ∈ B the
conditional densities fj(x
d−1
1 |xd) are not all equal on A(xd). Then equation (15)
becomes
0 = f0(x
d−1
1 |xd) −
m∑
j=1
c′j fj(x
d−1
1 |xd) xd−11 ∈ A(xd)
29
where c′j = cj fj(xd)/f0(xd). Our assumption regarding the conditional densities
ensures that fj(x
d−1
1 |xd) is different from f0(xd−11 |xd) for some j ≥ 1, again contra-
dicting the induction hypothesis. This completes the proof.
Lemma C.3. Let η(z) be local false discovery rate defined as
η(z) := P(Γ = 0 |Z = z) = p0f0(z)
f(z)
.
and assume that every diagonal entry of Σ is positive. Then the following hold.
1. infz∈Rd η(z) = 0.
2. For every c ≥ 0 the Lebesgue measure of the set {z : η(z) = c} in RK is zero.
Proof. Proof of 1: As η(z) is always positive, it is enough to show that there exists
z ∈ Rd and γ ∈ {0, 1}K such that f0(bz)/fγ(bz)→ 0 as b→∞. From the exponential
form of the multivariate normal densities, it can be seen that the last relation will
hold if the matrix ∆−1 − (∆ + Σ · γγT )−1 has an eigenvalue greater than zero.
Let x0 be an eigenvector of the matrix ∆ corresponding to the smallest eigenvalue
λmin(∆) (which is positive by assumption). Assume without loss of generality that
||x0|| = 1. Using the variational formula for eigenvalues, and the relationship between
the eigenvalues of a matrix and those of its inverse, we find that
λmax(∆
−1 − (∆ + Σ · γγT )−1) = max
z:||z||=1
zT (∆−1 − (∆ + Σ · γγT )−1)z
≥ max
z:||z||=1
zT∆−1z − max
z:||z||=1
zT (∆ + Σ · γγT )−1z
= λmax(∆
−1) − λmax((∆ + Σ · γγT )−1)
= λmin(∆) − λmin(∆ + Σ · γγT )
≥ xT0 ∆x0 − xT0 (∆ + Σ · γγT )x0
= xT0 (Σ · γγT )x0
Let 1 ≤ i ≤ K be any index for which x0,i 6= 0. If γ is the binary K-vector having
a 1 in position i and all other entries equal to 0, then it is easy to see that the last
expression above is σii x
2
0,i, which is positive.
Proof of 2: This follows immediately from Lemma C.2
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Proposition C.4. The function F (t) defined as
F (t) := E(η(Z) | η(Z) ≤ t) = E[η(Z) I(η(Z) ≤ t)]
P(η(Z) ≤ t) .
is continuous and strictly increasing on the interval (0, Lη), where Lη = supz∈Rd η(z) <
1.
Proof: Note that F (t) is of the form g(t) in (13) with U = η(Z). Part 2 of Lemma
C.3 establishes that P(η(bZ) = t) = 0, and continuity of F then follows from Lemma
C.1. For 0 < a < b < Lη we have
P(a < η(Z) < b) = P(η(Z) ∈ (a, b)) = P(Z ∈ η−1(a, b)).
As η(z) is continuous η−1(a, b) is an open subset of Rd. Moreover, η−1(a, b) is non-
empty by Part 1 of Lemma C.3. Thus P(a < η(Z) < b) > 0 as the density f of Z is
positive on Rd. Continuity of F (t) then follows from Lemma C.1.
C.2 Proof of Theorem 3.2
Lemma C.5. Let G1, G2, . . . : [0, 1] → R be non-decreasing functions. For fixed
α ∈ (0, Lη) define θn = sup{t : Gn(t) ≤ α} and let θ ∈ (0, 1) be the unique number
such that F (θ) = α. If Gn(t) → F (t) for each t in a dense subset T of [0, 1] then
θn → θ.
Proof. Suppose by way of contradiction that |θn−θ| 6→ 0. Then there exists δ1, δ2 > 0
such that {θ − δ1, θ + δ2} ⊆ T and an infinite subsequence nk of 1, 2, . . . such that
either θnk ≤ θ − 2δ1 for each k ≥ 1 or θnk ≥ θ + 2δ2 for each k ≥ 1. In the first case,
the definition of θn and the monotonicity of Gn imply
α ≤ Gnk(θnk + δ1) ≤ Gnk(θ − δ1)
Taking limits as k →∞ we find α ≤ F (θ− δ1) < α as F is strictly increasing, which
is a contradiction. In the second case, a similar argument shows that
α ≥ Gnk(θnk − δ2) ≥ Gnk(θ + δ2).
Taking limits as k → ∞ yields α ≥ F (θ + δ2) > α, which is again a contradiction.
This concludes the proof.
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Proof of Theorem 3.2: Let θˆn = sup{t : Fˆn(t) ≤ α} and let θ be the unique number
such that F (θ) = α. We claim that θˆn → θ in probability. To show this, assume to
the contrary that there exists δ > 0 and a subsequence nk such that
P
(|θˆnk − θ| > δ) > δ for each k ≥ 1. (16)
Let T be any countable, dense subset of [0, 1]. Our assumptions imply that Fˆn(t)→
F (t) in probability for each t ∈ T . By a standard diagonalization argument, there
exists a subsequence mk of nk such that Fˆmk(t)→ F (t) with probability one for each
t ∈ T . It then follows from Lemma C.5 that θˆmk → θ with probability one, which
contradicts (16).
In order to establish the theorem, it will be convenient to work with version of Mn
and Nn in which the data-dependent threshold θˆn is replaced by the limiting value θ.
Define
M˜n =
∑
λ∈Λn
I(Γλ = 0) I(η(Zλ) ≤ θ) and N˜n =
∑
λ∈Λn
I(η(Zλ) ≤ θ)
Note that EN˜n = |Λn| · P(η(Z) ≤ θ). By an elementary conditioning argument,
EM˜n =
∑
λ∈Λn
E
{
P(Γλ = 0 |Zλ) I(η(Zλ) ≤ tn(α))
}
=
∑
λ∈Λn
E
{
η(Zλ) I(η(Zλ) ≤ tn(α))
}
= |Λn| · E[η(Z) I(η(Z) ≤ t)].
For each δ > 0,
E|N˜n −Nn| ≤
∑
λ∈Λn
P(η(Zλ) ∈ [θˆn, θ] ∪ [θ, θˆn])
≤ |Λn|
[
P
(
η(Z) ∈ (θ − δ, θ + δ))+ P(|θˆn − θ| ≥ δ)].
As θˆn → θ in probability and the distribution of η(Z) has no point masses, the last
inequality implies that E|N˜n − Nn| = |Λn| · o(1). A similar argument shows that
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E|M˜n −Mn| = |Λn| · o(1). Thus as n tends to infinity,
EMn
ENn
=
EM˜n + |Λn| · o(1)
EN˜n + |Λn| · o(1)
=
E[η(Z) I(η(Z) ≤ θ)] + o(1)
P(η(Z) ≤ θ) + o(1)
→ E[η(Z) I(η(Z) ≤ θ)]
P(η(Z) ≤ θ) = F (θ) = α.
This completes the proof of the theorem.
D Simulation Study
In this section, we examine the performance of MT-eQTL through a simulation study
with K = 4 tissues. As the basis of the model and subsequent inferences is the
collection of z-statistic vectors derived from the observed genotype and transcript
data, we directly simulate the z-statistics.
D.1 Simulation Setting
We simulate 10 million vectors zλ independently from the MT-eQTL model using
parameters θ = (∆,Σ,p,µ0) obtained from eQTL analysis of data from the GTEx
initiative (we consider the tissues blood, lung, muscle, and thyroid, which we denote
by a, b, c, and d, respectively). Sample sizes, sample overlap, and degrees of freedom
after covariate correction are given in Table 1. The true model parameters are given
in Table 2. Note that the average effect size parameter µ0 is set to be zero in data
generation and model fitting for simplicity.We remark that allowing µ0 to be free has
little effect on the numerical results.
We simulated each vector zλ in a two-step fashion: first drawing γ ∈ {0, 1}4 from
p, and then drawing zλ from fγ(z) given γ. Access to the true configurations γ
enables us to assess false discovery rates associated with inferences from the fitted
model.
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D.2 Model Fit
The approximate EM procedure was used to fit the full 4-dimensional model, as well
as all possible 1-, 2-, and 3-dimensional models. We terminated EM updates when
the difference between log likelihoods in two consecutive iterations was less than 0.01.
The average number of iterations until convergence of the EM procedure was 80. The
running time of the EM procedure depended on the number of tissues in the model,
ranging from about 1 second per iteration for the 1-dimensional models to about 40
seconds per iteration for full 4-dimensional model on a standard desktop PC. Fitting
of the 4-dimensional model based on the simulated data took slightly more than one
hour.
As expected, the parameters estimated from the simulated data are very close
to those used to generate the data. For the 4-dimensional model, the relative error
of each entry of Σ is less than 0.3%, while the relative error for each entry of ∆ is
less than 0.7%. For the probability mass vector p, thirteen of sixteen entries had
relative error less than 1%, with the remaining relative errors equal to 1.45%, 1.66%
and 4.31%. These results confirm that the approximate EM procedure works well on
the simulated data.
D.3 Results
We apply the adaptive thresholding procedure to the local FDRs and detect eQTLs
with different configurations. In particular, we attempt to identify eQTLs in at least
one tissue, in a single tissue, and in all tissues. The corresponding null configurations
are shown in the second column of Table 3. In all studies, we fixed the nominal
FDR threshold at α = 0.05. Table 3 contains the number of true alternative cases,
the number of total discoveries, the number of overlaps (i.e., true positives), the true
positive rate (TPR), and the FDR in each study.
In all studies, the observed FDRs are strictly below the nominal level of 5%; and
the TPRs are around 40%. These TPRs are considered relatively high because many
alternative cases may have modest to small effect sizes in the simulated data, and are
not readily distinguishable from the null cases. This behavior is representative of real
data where signals are not always highly identifiable. The TPR for testing cross-tissue
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eQTL is the lowest among all cases because it is the most challenging problem: a cross-
tissue eQTL may be easily mistaken as other eQTL configurations (e.g., 1110, 1101,
1011, 0111, etc). Nonetheless, the TPR for such case is still reasonably high, which
demonstrates the efficacy of the proposed method. In addition, we emphasize that
our method is flexible enough to detect eQTL of different configurations. Numerical
results indicate that the method has great power in identifying significant association
between a gene and a SNP in a single tissue or in any tissue.
In order to assess how the use of auxiliary tissues increases statistical power of
detecting eQTL in a target tissue, we fit a series of nested MT-eQTL models for tissue
sets {a}, {a,b}, {a,b,c}, and {a,b,c,d} and only focused on eQTL detection in tissue a.
In each study, we fixed the target set S = {a}, and applied the adaptive thresholding
procedure to the marginal local FDR defined in Section 3.3 in the main article. We set
the nominal FDR at the level of 0.05 for all studies. As a result, the discoveries from
different studies are comparable, as they are all detected gene-SNP pairs with eQTL
in tissue a at the FDR of 0.05. Table 4 shows the TPRs and FDRs in different studies.
The number of true alternative cases is 1,596,410. The TPRs increase steadily with
the number of auxiliary tissues considered in the analysis, while the FDRs are all
controlled at the nominal level. The result indicates that by borrowing information
from auxiliary tissues, the model gains power of detecting eQTL in a target tissue
without inflating the FDR. Similar results hold for more sophisticated hypothesis
testings.
E GTEx Estimations
The sample information of the GTEx pilot data is provided in Figure 5. The estimated
model parameters ∆ and Σ for the GTEx data are given below. The tissues are
ordered alphabetically. The parameter µ0 was set to zero. The estimated mass
function p (prior probabilities for 512 configurations) is provided in a separate text
file (SuppC-p.txt) due to space limitations.
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Figure 5: Sample information of the GTEx data. Each column represents a genotyped
individual with expression measurements in at least one tissue; each row corresponds
to a tissue. Red means the individual is a donor of the corresponding tissue.
∆ =

1.0000 0.1704 0.0923 0.1010 0.1390 0.1409 0.1687 0.1415 0.1441
0.1704 1.0000 0.0960 0.1179 0.1518 0.1460 0.1942 0.1336 0.1491
0.0923 0.0960 1.0000 0.0779 0.1312 0.0780 0.1007 0.0890 0.1032
0.1010 0.1179 0.0779 1.0000 0.1268 0.1192 0.1093 0.0893 0.1247
0.1390 0.1518 0.1312 0.1268 1.0000 0.1188 0.1543 0.1220 0.1767
0.1409 0.1460 0.0780 0.1192 0.1188 1.0000 0.1366 0.1095 0.1258
0.1687 0.1942 0.1007 0.1093 0.1543 0.1366 1.0000 0.1372 0.1477
0.1415 0.1336 0.0890 0.0893 0.1220 0.1095 0.1372 1.0000 0.1097
0.1441 0.1491 0.1032 0.1247 0.1767 0.1258 0.1477 0.1097 1.0000

,
36
Σ =

4.2692 4.5320 4.1062 3.2993 4.6078 4.0864 4.2076 3.9694 4.4595
4.5320 5.4178 4.4545 3.6526 5.0411 4.5731 4.6975 4.3167 5.0072
4.1062 4.4545 6.1588 3.3196 5.0385 4.2452 4.0646 4.0090 4.5213
3.2993 3.6526 3.3196 3.2123 3.7223 3.6852 3.3418 3.1225 3.7332
4.6078 5.0411 5.0385 3.7223 5.5488 4.5088 4.6816 4.5263 5.2369
4.0864 4.5731 4.2452 3.6852 4.5088 5.1569 4.0399 3.9304 4.3674
4.2076 4.6975 4.0646 3.3418 4.6816 4.0399 4.5993 4.0265 4.6699
3.9694 4.3167 4.0090 3.1225 4.5263 3.9304 4.0265 4.3420 4.4163
4.4595 5.0072 4.5213 3.7332 5.2369 4.3674 4.6699 4.4163 5.6492

.
The fitting times of MT-eQTL and the Meta-Tissue method (Sul and others , 2013)
on a sequence of sub-models of different dimensions based on alphabetically ordered
tissues are presented in Table 5. (We note that fitting sub-models of MT-eQTL is
unnecessary in practice, as one can obtain them through marginalization of the full
model.) The use of configuration vectors in MT-eQTL makes analysis results more
interpretable, but it also makes the runtime of MT-eQTL sensitive to the number of
tissues. Nevertheless, our method is computationally efficient when the number of
tissues is moderate. On the other hand, the Meta-Tissue method is less restricted
by the number of tissues, but it is more sensitive to the total number of gene-SNP
pairs. The runtime for Meta-Tissue may quickly become impractical when there are
too many gene-SNP pairs.
Table 1: Sample sizes (diagonal), sample overlap (off-diagonal), and degrees of free-
dom for different tissues in the simulation.
a b c d Degree of Freedom
a 156 104 122 90 137
b 119 100 84 100
c 138 88 119
d 105 86
37
Table 2: The true generating model parameters (∆,Σ,p) for the simulation study.
The prior probabilities are provided for all possible eQTL configurations represented
by 4-digit 0/1 sequences: 0 means no eQTL and 1 indicates the presence of eQTL in
a tissue.
(a) ∆
a b c d
a 1.0000 0.1347 0.0805 0.1089
b 0.1347 1.0000 0.1204 0.1794
c 0.0805 0.1204 1.0000 0.1288
d 0.1089 0.1794 0.1288 1.0000
(b) Σ
a b c d
a 6.5699 5.3098 4.4683 4.7126
b 5.3098 5.9752 4.7906 5.5778
c 4.4683 4.7906 5.5263 4.6493
d 4.7126 5.5778 4.6493 6.0178
(c) p
Config (abcd) 0000 0001 0010 0011 0100 0101 0110 0111
Prior 0.7721 0.0202 0.0190 0.0037 0.0104 0.0033 0.0010 0.0107
Config (abcd) 1000 1001 1010 1011 1100 1101 1110 1111
Prior 0.0196 0.0010 0.0008 0.0009 0.0029 0.0085 0.0019 0.1240
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Table 3: A variety of eQTL detection inferences with the MT-eQTL model in the
4-tissue simulation study. From top to bottom, we aim to identify eQTLs: 1) in at
least one tissue; 2) in tissue a (the null consists of all configurations with 0 in the first
position); 3) in tissue b; 4) in tissue c; 5) in tissue d; 6) in all 4 tissues.
Index Null Config # Alternative Cases # Discoveries # Overlaps TPR FDR
1) 0000 2,279,307 1,038,456 987,083 .4331 .0495
2) 0*** 1,596,410 679,207 645,700 .4045 .0493
3) *0** 1,626,961 746,265 709,258 .4359 .0496
4) **0* 1,618,655 663,367 630,502 .3895 .0495
5) ***0 1,722,789 770,722 732,600 .4252 .0495
6) all but 1111 1,239,630 417,867 397,341 .3205 .0491
Table 4: The TPRs and FDRs of detecting eQTL in tissue a using the MT-eQTL
model on tissue sets {a}, {a,b}, {a,b,c}, and {a,b,c,d}.
{a} {a,b} {a,b,c} {a,b,c,d}
TPR .2753 .3475 .3806 .4045
FDR .0500 .0499 .0496 .0493
Table 5: Approximate fitting times for k-dimensional MT-eQTL models and Meta-
Tissue methods using the GTEx data.
Time k = 1 k = 2 k = 3 k = 4 k = 5 k = 6 k = 7 k = 8 k = 9
MT-eQTL < 1 min 15 min 30 min 1 hr 2.5hr 6hr 11hr 16 hr 24 hr
Meta-Tissue 130 min 165 min 165 min 3 hr 3 hr 3.25 hr 3.5 hr 4 hr 5 hr
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